BCSF BCSF
Company Profile ↓Company Overview
BCSF (BCSF) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 64.2% per year over the last five years.
Trades at an undemanding P/E of 8.3.
Recent Developments
- Trailing 12 Months Year-on-year growth — earnings -17.3%.
- 5-Year Trend Long-term compounding — profit CAGR 64.2%.
Growth & Price Performance
Compounded Profit Growth
| 5 Years: | 64.18% |
| 1 Year: | -17.30% |
Stock Price Performance
| 1 Year: | -0.58% |
| 6 Months: | +7.60% |
| 3 Months: | -6.78% |
| 1 Month: | -0.08% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)51.02 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 64.2% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -104.45M | 21.77M | 51.46M | 39.50M | 31.75M | 42.43M | 23.34M | 22.28M | 33.68M | 17.23M | 11.05M | 43.52M | 29.29M | 29.17M | 33.86M | 31.06M | 35.09M | 29.09M | 33.10M | 22.14M | 28.55M | 23.72M | 18.70M | 27.78M | 3.39M |
| Diluted EPS | -2.02 | 0.40 | 0.80 | 0.61 | 0.49 | 0.66 | 0.36 | 0.35 | 0.52 | 0.27 | 0.17 | 0.67 | 0.45 | 0.45 | 0.52 | 0.48 | 0.55 | 0.45 | 0.51 | 0.34 | 0.44 | 0.37 | 0.29 | 0.43 | 0.05 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Net Income | 8.28M | 119.81M | 105.48M | 123.38M | 119.42M | 98.76M |
| Diluted EPS | 0.14 | 1.86 | 1.63 | 1.91 | 1.85 | 1.53 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 2.57B | 2.59B | 2.47B | 2.63B | 2.66B |
| Total Equity | 1.02B | 1.07B | 1.10B | 1.12B | 1.14B | 1.14B | 1.12B |
| Cash & Equivalents | - | - | 87.44M | 30.20M | 42.99M | 51.56M | 23.09M |
| Long Term Debt | - | - | 1.41B | 1.39B | 1.26B | 1.39B | 1.47B |
| Total Liabilities | - | - | 1.47B | 1.48B | 1.34B | 1.49B | 1.55B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 89.42M | 265.55M | -316.83M | 219.26M | -27.10M | 29.52M |
| Financing Cash Flow | -76.52M | -138.63M | 238.33M | -231.43M | 14.25M | -71.88M |
| Dividends Paid | - | 87.81M | 87.80M | 99.43M | 114.28M | 145.82M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - |
| ROE % | 0.8% | 10.9% | 9.4% | 10.9% | 10.5% | 8.8% |
| ROCE % | - | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BCSF
Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the Second Quarter Ended June 30, 2026
BOSTON, July 23, 2026--Bain Capital Specialty Finance, Inc. (NYSE: BCSF, the "Company", "our" or "we") today announced it will report its financial results for the second quarter ended June 30, 2026 on Monday, August 10, 2026 after market c…
Bain Capital Specialty Finance (BCSF) Stock Sees Fair Value Cut After Q1 Analyst Revisions
The latest research on Bain Capital Specialty Finance centers on a reset to a US$13.50 price target, which frames how analysts are recalibrating expectations after the most recent quarterly results. The shift is paired with Neutral commenta…
Bain Capital Specialty (BCSF) Upgraded to Buy: What Does It Mean for the Stock?
Bain Capital Specialty (BCSF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Bain Capital Specialty Finance Inc (BCSF) Q1 2026 Earnings Call Highlights: Navigating Market ...
Despite facing unrealized losses and market volatility, Bain Capital Specialty Finance Inc (BCSF) maintains dividend coverage and explores new investment opportunities.
Bain Capital BCSF Q1 2026 Earnings Transcript
Good morning, and welcome, everyone, to the Bain Capital Specialty Finance First Quarter ended March 31, 2026 Conference Call. Yesterday, after market closed, we issued our earnings press release and investor presentation of our quarterly …
Bain Capital Specialty Finance Q1 Earnings Call Highlights
Bain Capital Specialty Finance (NYSE:BCSF) reported first-quarter net investment income that matched its regular dividend, while net income was pressured by unrealized losses tied to select portfolio companies and broader market valuation a…
BCSF — Frequently Asked Questions
What is the current share price of BCSF?
As of 2026-08-05 17:25 PDT, BCSF trades at $12.68 on NASDAQ/NYSE. Its 52-week range is $11.52 to $13.74.
What is the P/E ratio of BCSF?
BCSF trades at a trailing price-to-earnings (P/E) ratio of 8.29.
What is the return on equity (ROE) of BCSF?
BCSF has a return on equity (ROE) of 8.84%.
Is BCSF a good stock to buy?
This page provides a data-driven analysis of BCSF, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.